
|Videos|March 12, 2022
Augmenting corneal thickness with FDA-approved hypotonic riboflavin
Author(s)Alex Delaney-Gesing, Senior Editor
Daniel Fuller, OD, FAAO Dipl., FSLS, discusses augmenting corneal thickness in thin keratoconus corneas during corneal cross-linking via FDA-approved hypotonic riboflavin during SECO 2022.
Advertisement
Daniel Fuller, OD, FAAO Dipl., FSLS, discusses his SECO 2022 presentation "Augmenting corneal thickness in thin keratoconus corneas during corneal cross-linking via FDA-approved hypotonic riboflavin," with Optometry Times®' Alex Delaney-Gesing.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Optometry Times - Clinical News & Expert Optometrist Insights
1
FDA approves Lumvoa (veligrotug-vvze) for active and chronic thyroid eye disease
2
Myopia as a lifelong vision health condition: Long-term ocular risks and modern management strategies
3
AOA 2026: What fitting patients for comfortability looks like in daily practice
4
AOA 2026: Why some patients with dry eye feel pain and others do not
5
























